Continuous Electroencephalography During and After Convulsive Status Epilepticus: Scope, Significance, and Standards Authors: Gagandeep Singh, Monika Singla, Birinder S Paul, Dhananjay Gupta Published: 2026 ABSTRACT We report a case of super-refractory convulsive status epilepticus managed in our intensive care unit. Although the outcome was ultimately fatal, we present serial continuous electroencephalography (EEG) recordings obtained throughout this short but severe illness. Using this case as a framework, we explore the nuances and complexities of interpreting continuous EEG findings and related electrographic phenomena. In particular, we highlight the indications for continuous EEG monitoring based on validated instruments and examine the relationship between specific electrographic patterns and seizures or status epilepticus, including lateralized periodic discharges, lateralized rhythmic delta activity, generalized periodic discharges, and their modifiers. We also outline the evolving stages of status epilepticus as identified on continuous EEG, along with their therapeutic and prognostic implications. Finally, we demonstrate the role of continuous EEG in guiding therapeutic decision-making during status epilepticus, with particular emphasis on defining electrographic targets for anesthetic management. Introduction Status epilepticus represents the most severe and potentially catastrophic manifestation of epilepsy. Beyond the broader morbidity and mortality associated with epilepsy, status epilepticus is associated with mortality rates of approximately 20–30%, varying with etiology, clinical presentation, and duration.[12] Its management is often complex and demanding. While adherence to carefully developed local or institutional protocols is advisable, there remains a paucity of tools to guide treatment strategies and monitor response. Electroencephalography (EEG) is an excellent tool for monitoring brain function, prognosis, and seizures; however, conventional short-term EEG provides only a snapshot in time. As such, it cannot adequately capture treatment response, or lack thereof, and therefore has limited ability to guide ongoing therapeutic adjustments. In this setting, numerous critical decisions must be made, including when to initiate anesthetic therapy, when to escalate treatment, when to add or substitute anesthetic agents, and when to begin tapering or discontinuing anesthetics. Continuous EEG offers a powerful means of capturing electrographic signatures and surrogate markers in real time and thus has significant potential to inform and guide these decisions.[3] As evidence supporting the utility of continuous EEG in seizures and status epilepticus continues to emerge and accumulate, we present a single-case–based analysis that traces EEG findings alongside clinical features and therapeutic adjustments. Using a scene–act framework with guided questions for each act, we review the role and interpretation of various EEG findings. This approach highlights the role of continuous EEG across different stages of status epilepticus management. Case Vignette Scene 1: The setting is the hospital emergency department. Act 1: A 34-year-old previously healthy man was brought to the emergency room in an unconscious state. On initial assessment, the triaging internal medicine resident recorded a Glasgow Coma Scale score of E1V (intubated) M2. According to accompanying relatives, the patient had been well until four days earlier, when he developed fever associated with altered mentation and sensorium. Approximately 14 hours before presentation, he experienced multiple episodes of generalized tonic–clonic seizures without recovery of consciousness between them. At an outside hospital, he received lorazepam (4 mg IV), levetiracetam (60 mg/kg), lacosamide (400 mg IV in two divided doses), and phenobarbital (1 g IV). Due to ongoing seizures, he was intubated and started on a midazolam infusion before transfer to our facility. A brain magnetic resonance imaging (MRI) was also conducted and was reported as normal. On arrival, he was no longer convulsing, had no focal neurological deficits, and his vital signs were stable. Act 2: Shortly after arrival in the emergency department, the patient had a generalized tonic–clonic seizure. The emergency department resident administered an additional 10 mg of midazolam, which terminated the seizure within 3–4 minutes. Concurrently, the nurse collected routine blood samples, and a stat EEG was requested in light of the ongoing seizure activity. Key question 1: How can an EEG examination help guide management at this stage? Answer: Immediately after a seizure, a patient may remain unconscious for a variable period, typically 10–20 minutes. This is the postictal state, from which the patient recovers quickly. However, if consciousness does not return within this timeframe despite cessation of convulsive seizure activity, several possibilities should be considered: (i) a prolonged postictal state, which may follow the occurrence of a prolonged seizure or status epilepticus; (ii) coma due to the underlying etiology of status epilepticus (e.g., traumatic brain injury, stroke, or encephalitis); and (iii) ongoing seizures in the form of nonconvulsive status epilepticus (NCSE), including recurrent nonconvulsive seizures. It is estimated that the latter is a sequel to convulsive status epilepticus in nearly one-half of the cases.[4] Moreover, NCSE represents an enduring convulsive status epilepticus in which tonic–clonic motor manifestations have ceased, possibly due to exhaustion of synaptic transmission in descending reticulospinal pathways.[5] Recognition of NCSE can be crucial and is possible only with the aid of continuous EEG, as it is associated with at least a 20% increase in mortality.[6] The American Clinical Neurophysiology Society (ACNS) recommends continuous EEG if consciousness does not recover after a convulsive seizure.[7] The European Society of Intensive Care Medicine recommends continuous EEG if consciousness is not regained within 60 minutes.[8] At our center, we aim to conduct an EEG as soon as possible after a patient with a seizure presents to the emergency department.[9] Furthermore, we would undertake, at minimum, a short, one-hour bedside EEG using a portable EEG machine in the emergency room if consciousness does not return within 10–15 minutes after a brief convulsive seizure. This recording should be reviewed in real time to detect nonconvulsive seizures or NCSE and to obtain diagnostic and prognostic information, including the probability of occurrence of further seizures within the next 24–48 hours. The risk of subsequent seizures—and thus the need for continuous EEG—is estimated using the 2HELP2B score derived from this initial recording.[10] Continuous EEG of longer duration is indicated following convulsive status epilepticus regardless of initial findings. If the first one-hour recording discloses electrographic seizures, with or without subtle manifestations (i.e., nonconvulsive or convulsive seizures), we recommend continuing the EEG monitoring for at least 24 hours, typically in the intensive care unit.[478] If no nonconvulsive seizures are identified in the first one hour of recording, we recommend estimating the 2HELP2B score [Table 1].[10] To estimate the 2HELP2B score, we review the initial one-hour EEG to identify the following: (i) lateralized periodic discharges (LPDs) or bilateral independent periodic discharges (BIPDs) or lateralized rhythmic delta activity (LRDA); (ii) brief potentially ictal rhythmic discharges (BIRDs); (iii) other focal or generalized epileptiform discharges; and (iv) a discharge frequency > 2 Hz (i.e., ≥3 discharges per second) (see Table 2 for definitions). Table 12HELP2B score[10]Components of the 2HELPS2B Score ComponentPointsB – Brief potentially ictal rhythmic discharges (BIRDs)2 H – Lateralized periodic discharges (LPDs) or lateralized rhythmic delta activity (LRDA)1 E – Seizure before scoring period1 L – Lateralized slowing1 P – Periodic discharges - generalized1 S – Sporadic epileptiform discharges (spikes/sharp waves)1 2 – Frequency ≥2 Hz for any periodic/rhythmic pattern1 Maximum score = 7 Estimated Seizure Risk by Score Total score Approximate seizure risk 0~3–5% 1~10% 2~25–30% 3~50% ≥4≥70–80% Exact percentages vary slightly across validation cohorts 2HELP2B score[10] Table 2American College of Clinical Neurophysiology definitions and criteria for selected electrographic phenomena within the ictal–interictal continuum[11]ACNS critical care EEG patterns FeatureLateralized rhythmic periodic discharges (LPDs)Lateralized rhythmic delta activity (LRDA)Generalized rhythmic delta activity (GRDA)Generalized periodic discharges (GPDs; formerly GPEDs)Basic pattern typePeriodic dischargesRhythmic activityRhythmic activityPeriodic discharges DistributionUnilateral/one hemisphereLateralizedGeneralizedBilateral, synchronous, generalized Frequency rangeTypically 0.5–2.5 Hz (may be higher)0.5–4 Hz (delta range)0.5–4 Hz (delta range)Typically 0.5–2.5 Hz (may be higher) PeriodicityYes, clear inter-discharge intervalNo, continuous rhythmic pattern without discrete intervalsNo, continuous rhythmic pattern without discrete intervalsYes, recurring at nearly regular intervals MorphologySharp waves, spikes, complex waveformsSinusoidal or sharply contoured deltaSinusoidal or sharply contoured deltaSpikes, sharp waves, triphasic morphology possible Common modifiers+Fast rhythm, +Rhythmic slow, +Both+Fast rhythm, +Sharp/Spike, +Both+Fast rhythm, +Sharp/Spike, +Both+Fast rhythm, +Rhythmic slow, +Both Association with seizures++++++++++++++; increases with higher frequency (>1.5–2 Hz) Common etiologiesAcute focal structural lesion (stroke, tumor, encephalitis)Focal lesionDiffuse encephalopathyToxic-metabolic states, anoxia, infections Ictal–interictal continuum (IIC)+++++++++++; On IIC depending on frequency and evolution Key distinguishing featureLateralized+periodicRhythmic but not periodicRhythmic but not periodicGeneralized + periodic American College of Clinical Neurophysiology definitions and criteria for selected electrographic phenomena within the ictal–interictal continuum[11] The 2HELP2B score has demonstrated robust performance, with calibration errors <5% in validation studies.[121314] A minimum score of 1 is associated with an approximate 10% risk of seizures within the next 24 hours [Table 1]. Thresholds for initiating continuous EEG vary across institutions, as no formal guidelines currently exist. At our center, we initiate continuous EEG when the estimated 24-hour seizure risk exceeds 10%, (i.e., a 2HELP2B score of 1). Accordingly, continuous EEG is also warranted after one or more clinical or electrographic seizures, including status epilepticus. Higher 2HELP2B scores indicate progressively greater 24-hour seizure risks—approximately 25% with a score of 2, 50% with a score of 3, and 75% with a score of 4.[10] The 2HELP2B score primarily guides decisions regarding continuation of EEG monitoring rather than direct treatment choices. In addition to estimating overall yield of seizures during 24-hour continuous EEG, the timing of seizure detection is also important. A study evaluating the yield of continuous EEG in critically ill patients demonstrated that, among those in whom seizure occur, approximately 50% are detected within the first hour of monitoring and 80% within 24 hours.[15] Furthermore, it may be useful to semiquantitatively assess individual components of the 2HELP2B score during the initial hour of recording, namely epileptiform discharges, LPDs, LRDA, BIPDs, or BIRDs. This could be done using an ordinal scale: continuous (>90% of the record), abundant (50–89%), frequent (10–49%), occasional (1–9%), and rare (<1%).[11] Although the prevalence of these EEG abnormalities may intuitively correlate with seizure risk, this approach has not been supported by robust validation. At our center, we routinely document the prevalence of EEG abnormalities.[16] Although this does not influence the decision to initiate continuous EEG, it provides prognostic insight and serves as a reference for comparison on follow-up EEG recordings. Case report (cont’d) Scene 2: The setting is the hospital Neuro-Intensive Treatment Unit. Act 2: The patient was shifted to the intensive care unit, where overnight continuous EEG monitoring was performed. During this period, no clinical or electrographic seizures were recorded; however, several brief electrographic discharges were recorded. Key question 2: What are stimulus-induced rhythmic, periodic, or ictal-appearing discharges (SIRPIDs), and how do these and other electrographic phenomena within the ictal–interictal continuum influence decision-making in the management of status epilepticus? Answer: SIRPIDs are EEG patterns that emerge in response to external stimulation and resolve when the stimulus ceases or diminishes, distinguishing them from electrographic seizures, which typically occur spontaneously and show clear temporal, spatial, or morphological evolution.[17] Although SIRPIDs may resemble ictal activity, they generally lack sustained evolution and clinical correlation and therefore do not meet ACNS criteria for electrographic seizures. Instead, they reflect transient cortical hyperexcitability in the setting of focal or generalized acute brain injury, most often in critically ill patients, and are best interpreted as markers of seizure vulnerability rather than seizures themselves. The strength of their association with seizures has not been extensively studied, largely due to their relative rarity, and remains contentious and controversial. In one study, SIRPIDs were not significantly associated with an increased incidence of acute seizures.[16] In our view, this was due to the small number of SIRIPIDs in the study sample. Despite, the resemblance to ictal discharges, SIRPIDs are best conceptualized as lying along the ictal–interictal continuum (IIC) likely closer to the interictal end. Notably, SIRIPIDs are found to occur later in the course of status epilepticus. Nevertheless, their presence warrants careful clinical and electrographic monitoring rather than reflex escalation of antiseizure therapy; management decisions should be guided by the overall clinical context rather than by their presence alone in the EEG. This case study clearly demonstrates the association of SIRIPIDs with an ongoing propensity for status epilepticus (see below) [Figure 1a]. (a) Stimulus-induced repetitive ictal discharges; (b). lateralized periodic discharges–plus (LPD-plus). LPD: Lateralized rhythmic periodic discharge The following section addresses other electrographic patterns that, similar to SIRPIDs, are not conclusively ictal and are categorized within the IIC.[18] To understand this continuum, it is first necessary to define what is definitively ictal activity. The Salzburg criteria were developed to provide standardized diagnostic criteria for NCSE.[19] According to the Salzburg criteria, NCSE is diagnosed when repetitive epileptiform discharges occur at a frequency of ≥3 Hz. When the discharge frequency is <3 Hz, additional features are required, such as subtle clinical manifestations time-locked to EEG discharges, clear evolution in frequency, morphology, or spatial distribution, or resolution of discharges with accompanying clinical improvement following administration of antiseizure medication (ASM).[19] These criteria have been robustly validated and are widely accepted in clinical practice.[2021] In addition to SIRPIDs, several other electrographic patterns fall within the IIC framework, including LPDs, GPDs, BIPDs, and LRDA.[11] Standardized definitions and terminology for these patterns are provided by the ACNS and are summarized in Table 1. Among these electrographic phenomena, LPDs carry the highest risk of acute seizures, followed by LRDA and GPDs. Approximately half of patients with LPDs experience seizures during the acute phase of their illness.[16222324] Seizure propensity across IIC patterns varies and is influenced by several factors: (i) the prevalence of the pattern within the EEG record, as graded by current ACNS terminology (see above); (ii) discharge frequency; and (iii) the presence of “plus” features (ACNS modifiers). Greater pattern prevalence correlates with higher seizure risk, although not in a precisely quantifiable manner.[11] Discharge frequency is also important; a threshold of 1.5 Hz has been empirically adopted by the ACNS to indicate increased seizure propensity. In one study, LRDA and GPDs occurring at frequencies >1.5 Hz were associated with a significantly higher likelihood of acute seizures.[16] Finally, the presence of “plus” features further increases seizure risk. For example, LPDs accompanied by superimposed fast activity or rhythmic delta activity are termed LPDs-plus [Figure 1b], and are associated with a higher incidence of acute seizures compared with LPDs without such modifiers. In one study, seizures occurred in 58% of EEG recordings demonstrating LPDs-plus, compared with 36% of recordings showing LPDs without plus features.[16] Act 3: On the following day, several discrete electrographic seizures were recorded, without concomitant clinical manifestations [Figure 2a]. At this point, the midazolam infusion was tapered and substituted with propofol. The propofol infusion was rapidly up-titrated to 400 mg/hour. At this stage, the EEG demonstrated a burst-suppression pattern [Figure 2b]. (a) Discrete electrographic seizures; (b) burst suppression Key Question 3: How does EEG help in staging status epilepticus? Answer: A stepwise evolution of EEG abnormalities in status epilepticus was first described nearly 35 years ago by Treiman et al. (1989) [Table 3],[25] based on sequential human and animal EEG recordings. The pattern typically progresses from discrete electrographic seizures to coalescing seizures, then to continuous ictal activity, followed by continuous ictal discharges interspersed with periods of EEG suppression, and ultimately to generalized periodic epileptiform discharges (GPDs). Table 3Electrographic stages of convulsive status epilepticus[25]Stage 1: Discrete seizures without background suppression [Figure 2a]Stage 2: Merging seizures without background suppression [Figure 4a]Stage 3: Continuous seizures without background suppression [Figure 4b]Stage 4: Generalized periodic epileptiform discharges (GPEDs)Stage 5: Electrocerebral silence Electrographic stages of convulsive status epilepticus[25] In modern practice, however, this orderly sequence is infrequently observed, largely due to the early and escalating use of ASMs and anesthetic agents in the management of status epilepticus. Consequently, strict progression through these electrographic stages is uncommon in patients receiving anesthetic therapy. In a single case report in which anesthetic treatment was withheld at the family’s request, the full sequence of EEG stages was documented over approximately 22 hours, culminating in electrocerebral silence.[26] It is also important to distinguish Stage V (GPDs) from burst suppression (see below), the latter typically being induced by anesthetic treatment. Early studies underscored the prognostic implications of these EEG stages, and we concur that Stages I and II are more likely to respond to anesthetic intervention, whereas advanced stages (IV and V) may indicate a point of limited reversibility.[27] In the present case, the EEG up to this point can be characterized as Stage I, representing discrete seizures. Key question 4: How does EEG help guide the management of status epilepticus? Answer: Continuous EEG supports the management of status epilepticus in several key ways: Guiding treatment escalation:Identification of discrete or evolving seizures helps inform decisions to initiate or escalate anesthetic therapy, either by increasing the dose of existing agents or by introducing or switching anesthetic medications. In the present case, recognition of discrete electrographic seizures prompted initiation and subsequent escalation of propofol dosing. This is especially relevant in the follow-up of convulsive status epilepticus, when overt motor activity may cease, presumably due to exhaustion of descending reticulospinal pathways, leaving EEG as the only indicator of ongoing seizure activity. In our view, detection of discrete electrographic seizures warrants escalation of anesthetic therapy.Defining therapeutic endpoints:Continuous EEG provides an objective treatment endpoint, although the optimal target remains debated. Proposed endpoints include cessation of electrographic seizures, induction of burst suppression, or, in some cases, complete suppression of EEG activity.Guiding de-escalation and detecting recurrence:Continuous EEG is also valuable during withdrawal of anesthetic agents, helping guide de-escalation and detecting breakthrough or rebound seizures during the weaning phase. This aspect is illustrated in the subsequent section. Guiding treatment escalation:Identification of discrete or evolving seizures helps inform decisions to initiate or escalate anesthetic therapy, either by increasing the dose of existing agents or by introducing or switching anesthetic medications. In the present case, recognition of discrete electrographic seizures prompted initiation and subsequent escalation of propofol dosing. This is especially relevant in the follow-up of convulsive status epilepticus, when overt motor activity may cease, presumably due to exhaustion of descending reticulospinal pathways, leaving EEG as the only indicator of ongoing seizure activity. In our view, detection of discrete electrographic seizures warrants escalation of anesthetic therapy. Guiding treatment escalation: Identification of discrete or evolving seizures helps inform decisions to initiate or escalate anesthetic therapy, either by increasing the dose of existing agents or by introducing or switching anesthetic medications. In the present case, recognition of discrete electrographic seizures prompted initiation and subsequent escalation of propofol dosing. This is especially relevant in the follow-up of convulsive status epilepticus, when overt motor activity may cease, presumably due to exhaustion of descending reticulospinal pathways, leaving EEG as the only indicator of ongoing seizure activity. In our view, detection of discrete electrographic seizures warrants escalation of anesthetic therapy. Defining therapeutic endpoints:Continuous EEG provides an objective treatment endpoint, although the optimal target remains debated. Proposed endpoints include cessation of electrographic seizures, induction of burst suppression, or, in some cases, complete suppression of EEG activity. Defining therapeutic endpoints: Continuous EEG provides an objective treatment endpoint, although the optimal target remains debated. Proposed endpoints include cessation of electrographic seizures, induction of burst suppression, or, in some cases, complete suppression of EEG activity. Guiding de-escalation and detecting recurrence:Continuous EEG is also valuable during withdrawal of anesthetic agents, helping guide de-escalation and detecting breakthrough or rebound seizures during the weaning phase. This aspect is illustrated in the subsequent section. Guiding de-escalation and detecting recurrence: Continuous EEG is also valuable during withdrawal of anesthetic agents, helping guide de-escalation and detecting breakthrough or rebound seizures during the weaning phase. This aspect is illustrated in the subsequent section. It is important to emphasize that the management of status epilepticus is dynamic and should be individualized, taking into account both the patient’s clinical condition and EEG findings. Each patient is unique, and the significance of EEG patterns may vary across different time points in the recording. Act 4: However, within 12 hours of the high-dose propofol infusion commencement, breakthrough seizures occurred despite burst suppression. The propofol infusion was gradually tapered while a combination of midazolam and ketamine infusions was initiated. Intravenous methylprednisolone was also initiated. No clinical or electrographic seizures were observed for 24 hours. At this point, a gradual taper of the infusions was planned. Key Question 5: What are the EEG-based therapeutic goals in the management of refractory status epilepticus (RSE)? Answer: At this stage, the present case represents super-refractory status epilepticus (SRSE). RSE is defined as ongoing seizures that fail to respond to second-line therapy, i.e., persistence despite an initial benzodiazepine followed by an adequately dosed ASM.[28] SRSE is conventionally defined as RSE in which seizures continue or recur beyond 24 hours of appropriately initiated treatment, including anesthetic therapy.[29] Anesthetic agents form the cornerstone of treatment in RSE and SRSE. Management goals in SRSE include: (i) termination of active seizures; (ii) prevention of breakthrough seizures during adequate anesthetic dosing; (iii) avoidance of rebound (withdrawal) seizures during anesthetic tapering; and (iv) minimization of the systemic and neurological complications of prolonged status epilepticus. One proposed EEG-based therapeutic target in SRSE is the induction of burst suppression. According to the ACNS, burst suppression is characterized by bursts lasting more than 0.5 seconds alternating with suppression periods during which EEG amplitude is <10 μV.[11] Other potential EEG targets include complete cessation of electrographic seizures or, at the extreme, total suppression of cerebral activity. However, high-quality evidence supporting any specific EEG target in SRSE is lacking. Available data are largely retrospective and confounded by heterogeneity in anesthetic regimens, treatment settings, and the use (or absence) of continuous EEG monitoring.[303132] Although several studies suggest that achieving burst suppression reduces the frequency of breakthrough seizures, it does not appear to decrease, and may even increase, the risk of withdrawal seizures during anesthetic tapering. A systematic review reported a higher incidence of hypotension associated with burst suppression, without a demonstrable impact on overall outcomes, including mortality.[31] Conversely, a retrospective study using midazolam to induce burst suppression found no effect on short- or long-term outcomes.[32] In our experience, achieving burst suppression can be challenging, even with optimal or supratherapeutic anesthetic dosing. In such cases, escalating to excessive doses solely to achieve burst suppression may not be justified. Instead, maintaining seizure control with maximally tolerated anesthetic doses may be a more pragmatic and safer approach. One study reported successful induction of burst suppression in only approximately three-quarters of cases in which it was attempted.[32] Given the absence of high-quality evidence, clinicians must carefully balance the risk of breakthrough seizures against the potential harm of deep sedation. We also assess burst morphology, particularly for interspersed epileptiform discharges, as their presence appears to predict a higher likelihood of both breakthrough and withdrawal seizures. Bursts containing epileptiform discharges [Figure 3a] should be distinguished from non-epileptiform bursts [Figure 3b]. One report also associated epileptiform bursts with relatively poorer prognosis compared with non-epileptiform bursts.[33] Burst suppression: (a) epileptiform; (b) – non-epileptiform Act 5: Electrographic seizures recurred within a few hours of initiating the taper and persisted despite increasing the dose [Figure 3a and b]. ]. Therapy was switched to propofol and subsequently to thiopental infusion (maximum dose: 550 mg/hour). A loading dose of perampanel (36 mg) was administered via a nasogastric tube. Nasogastric feeds were stopped with the intention of initiating a ketogenic diet via the route. The EEG then showed prolonged periods of suppression lasting up to 10 minutes; accordingly, the thiopental dose was reduced. Key Question 6: What do the EEG graphs in Figures 4a and b depict? Status epilepticus: (a) merging seizures; (b) continuous ictal activity; (c) generalized periodic epileptiform discharges with short suppression intervals; (d) generalized periodic epileptiform discharges with long suppression intervals Answer: The EEG demonstrates merging seizures with waxing and waning activity [Figure 4a] and continuous seizures [Figure 4b], in which electrographic ictal activity persists monotonously without clear evolution. As noted earlier, these patterns represent different stages of status epilepticus, each with prognostic implications in terms of response to anesthetic therapy. Key Question 7: What does the prolonged suppression with short bursts in Figures 4c and d indicate? Answer: The EEG shows suppression with interspersed generalized epileptiform discharges [Figure 4c]. These are consistent with generalized periodic discharges and represent an advanced stage of status epilepticus, which typically responds poorly to anesthetic therapy. Subsequently, the EEG evolved to show very prolonged periods of suppression [Figure 4d]. This may reflect either increasing depth of anesthesia at the administered doses or a deterioration in brain activity due to the underlying disease, hypoxia, or cytotoxic cerebral edema. In either scenario, it is appropriate to reduce the dose of the anesthetic agent while carefully monitoring for withdrawal seizures. Act 6 (The Final Act): The periods of suppression inexorably lengthened, and the patient eventually succumbed despite all measures. In conclusion, this discussion highlights the scope and limitations of continuous EEG, particularly the challenges of interpretation in the management of SRSE. We have not addressed logistical considerations, which are also highly relevant, especially given the time, financial, and manpower constraints under which many centers in India operate. We believe that tailoring EEG utilization and interpretation to the specific circumstances and resources of each institution is essential for optimal management of status epilepticus, while recognizing that continuous EEG can play a pivotal role in guiding treatment. Persistence and a systematic, stepwise approach are critical in managing SRSE. Seizure control may still be achieved after multiple courses of anesthetic therapy, and in selected patients, continuing or cycling anesthetic agents remains a viable strategy. Equally important, efforts to control seizures should be accompanied by ongoing evaluation and management of the underlying etiology. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Conflicts of interest GS in Chair of Education Council, International League Against Epilepsy and Vice-President (SEA) International Bureau for Epilepsy.